Literature DB >> 35581340

Achieving health equity in liver disease pharmacotherapy.

Ani Kardashian1, Lauren D Nephew2,3.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35581340     DOI: 10.1038/s41575-022-00632-8

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   73.082


× No keyword cloud information.
  2 in total

1.  Hepatology Highlights.

Authors:  Davide Povero; Joseph C Ahn; Jorge Arnold; Prowpanga Udompap; Sumera I Ilyas; Juan Pablo Arab
Journal:  Hepatology       Date:  2022-07       Impact factor: 17.298

2.  Racial and ethnic disparities in rifaximin use and subspecialty referrals for patients with hepatic encephalopathy in the United States.

Authors:  Elliot B Tapper; Utibe R Essien; Zhe Zhao; Nneka N Ufere; Neehar D Parikh
Journal:  J Hepatol       Date:  2022-03-30       Impact factor: 30.083

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.